CIA
IART icon

CSat Investment Advisory’s Integra LifeSciences IART Stock Holding History

CSat Investment Advisory’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-741
Closed -$35K – 731
2020
Q3 		$35K Buy
741
+86
+13% +$4.09K ﹤0.01% 732
2020
Q2 		$31K Buy
655
+329
+101% +$16.2K ﹤0.01% 740
2020
Q1 		$15K Buy
326
+46
+16% +$2.41K ﹤0.01% 789
2019
Q4 		$16K Buy
280
+47
+20% +$2.8K ﹤0.01% 852
2019
Q3 		$14K Buy
233
+32
+16% +$1.91K ﹤0.01% 812
2019
Q2 		$11K Buy
+201
New +$10.4K ﹤0.01% 843

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CSat Investment Advisory's IART Position: Q4 2020 in Review

CSat Investment Advisory sold out of Integra LifeSciences (IART) in Q4 2020, closing a stake of 741 shares — an estimated $35K sold.

CSat Investment Advisory first reported a position in IART in Q2 2019 and held it in 6 quarters. The position peaked at $35K in Q3 2020. 251 funds tracked by Wall St. Rank hold IART as of Q4 2020.

  • CSat Investment Advisory reported no remaining Integra LifeSciences position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 741 Integra LifeSciences shares in Q4 2020, an estimated $35K.
  • CSat Investment Advisory first reported a position in Integra LifeSciences in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Integra LifeSciences position peaked at $35K in Q3 2020.
  • 251 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.